Paper31322224
Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin.
Deng M and 8 others. Mol Med Rep, 2019. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin. Papers, record 31322224. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31322224
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carboplatin | Major topic |
| Minichromosome Maintenance Complex Component 2 | Major topic |
| Ovarian Neoplasms | Major topic |
| RNA Interference | Major topic |
| Apoptosis | |
| Cell Line, Tumor | |
| DNA Damage | |
| Female | |
| Humans | |
| RNA, Small Interfering |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10065148 | The dual role model for p53 in maintaining genomic integrity. | Cell Mol Life Sci | 1999 | https://conductscience.org/library/papers/10065148 | PubMed |
| 2 | 10101801 | p53 and apoptosis. | Semin Cancer Biol | 1998 | https://conductscience.org/library/papers/10101801 | PubMed |
| 3 | 10459007 | Mcm2, but not RPA, is a component of the mammalian early G1-phase prereplication complex. | J Cell Biol | 1999 | https://conductscience.org/library/papers/10459007 | PubMed |
| 4 | 10665656 | Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways. | Jpn J Cancer Res | 1999 | https://conductscience.org/library/papers/10665656 | PubMed |
| 5 | 10697522 | De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line. | Anticancer Res | 1999 | https://conductscience.org/library/papers/10697522 | PubMed |
| 6 | 11493639 | DNA replication licensing and human cell proliferation. | J Cell Sci | 2001 | https://conductscience.org/library/papers/11493639 | PubMed |
| 7 | 11577478 | Cancer statistics, 2001. | CA Cancer J Clin | 2001 | https://conductscience.org/library/papers/11577478 | PubMed |
| 8 | 11774736 | p53 gene status and chemosensitivity in ovarian cancer. | Hum Cell | 2001 | https://conductscience.org/library/papers/11774736 | PubMed |
| 9 | 12045100 | DNA replication in eukaryotic cells. | Annu Rev Biochem | 2002 | https://conductscience.org/library/papers/12045100 | PubMed |
| 10 | 12539237 | Paradoxes of eukaryotic DNA replication: MCM proteins and the random completion problem. | Bioessays | 2003 | https://conductscience.org/library/papers/12539237 | PubMed |
| 11 | 12901728 | Minichromosome maintenance 2 expression is correlated with mode of invasion and prognosis in oral squamous cell carcinomas. | J Oral Pathol Med | 2003 | https://conductscience.org/library/papers/12901728 | PubMed |
| 12 | 14612534 | Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells. | Cancer Res | 2003 | https://conductscience.org/library/papers/14612534 | PubMed |
| 13 | 14635251 | Perpetuating the double helix: molecular machines at eukaryotic DNA replication origins. | Bioessays | 2003 | https://conductscience.org/library/papers/14635251 | PubMed |
| 14 | 14661040 | Primary ovarian cancer chemotherapy: current standards of care. | Br J Cancer | 2003 | https://conductscience.org/library/papers/14661040 | PubMed |
| 15 | 15007098 | Eukaryotic MCM proteins: beyond replication initiation. | Microbiol Mol Biol Rev | 2004 | https://conductscience.org/library/papers/15007098 | PubMed |
| 16 | 15083189 | A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens. | Br J Cancer | 2004 | https://conductscience.org/library/papers/15083189 | PubMed |
| 17 | 15096526 | The role of Cdc6 in ensuring complete genome licensing and S phase checkpoint activation. | J Cell Biol | 2004 | https://conductscience.org/library/papers/15096526 | PubMed |
| 18 | 15210935 | Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15210935 | PubMed |
| 19 | 15538388 | Interaction between human MCM7 and Rad17 proteins is required for replication checkpoint signaling. | EMBO J | 2004 | https://conductscience.org/library/papers/15538388 | PubMed |
| 20 | 15814627 | Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/15814627 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42975739 | Integrative multi-omics analysis reveals a GALNT6/Smad2/CDC7 axis promoting cisplatin resistance through enhanced DNA damage repair in bladder cancer. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42975739 | PubMed |
| 41940421 | Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/41940421 | PubMed |
| 41795017 | CDK4/6i reverse PARPi resistance by targeting the E2F1- MCM2/5 pathway. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/41795017 | PubMed |
| 40440106 | Discovery and Mechanism of 16-19F, a Novel Synthetic Lethal Inhibitor of the PRMT5•MTA Complex in MTAP-Deleted Cancer Cells. | ACS Chem Biol | 2025 | https://conductscience.org/library/papers/40440106 | PubMed |
| 40248198 | Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications. | Front Oncol | 2025 | https://conductscience.org/library/papers/40248198 | PubMed |
| 40175339 | ABCB1 confers resistance to carboplatin by accumulating stem-like cells in the G2/M phase of the cell cycle in p53null ovarian cancer. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40175339 | PubMed |
| 39309198 | Proteomics and Bioinformatics Investigations Link Overexpression of FGF8 and Associated Hub Genes to the Progression of Ovarian Cancer and Poor Prognosis. | Biochem Res Int | 2024 | https://conductscience.org/library/papers/39309198 | PubMed |
| 38841623 | Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach. | EPMA J | 2024 | https://conductscience.org/library/papers/38841623 | PubMed |
| 37529110 | Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis. | Turk J Biol | 2023 | https://conductscience.org/library/papers/37529110 | PubMed |
| 37480569 | KNTC1 and MCM2 are the molecular targets of gallbladder cancer. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37480569 | PubMed |
| 36776764 | DNA replication: Mechanisms and therapeutic interventions for diseases. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/36776764 | PubMed |
| 36303105 | MCM2 in human cancer: functions, mechanisms, and clinical significance. | Mol Med | 2022 | https://conductscience.org/library/papers/36303105 | PubMed |
| 35924161 | Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35924161 | PubMed |
| 35693940 | Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35693940 | PubMed |
| 35173548 | DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/35173548 | PubMed |
| 35056094 | BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/35056094 | PubMed |
| 34859821 | Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma. | Biosci Rep | 2021 | https://conductscience.org/library/papers/34859821 | PubMed |
| 34670865 | GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress. | Mol Cancer Res | 2022 | https://conductscience.org/library/papers/34670865 | PubMed |
| 34440557 | Novel Therapies for Tongue Squamous Cell Carcinoma Patients with High-Grade Tumors. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34440557 | PubMed |
| 34178669 | Systemic Analysis of the DNA Replication Regulator MCM Complex in Ovarian Cancer and Its Prognostic Value. | Front Oncol | 2021 | https://conductscience.org/library/papers/34178669 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| CHEK2 | 11200 | PubTator's text mining | https://conductscience.org/library/genes/11200 | NCBI Gene |
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| MCM2 | 4171 | PubTator's text mining | https://conductscience.org/library/genes/4171 | NCBI Gene |
| NSF | 4905 | PubTator's text mining | https://conductscience.org/library/genes/4905 | NCBI Gene |
| PIK3CA | 5290 | PubTator's text mining | https://conductscience.org/library/genes/5290 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31322224
GET https://conductscience.org/api/papers/v1/31322224/references?page=2